The human epidermal growth factor receptor 2 (HER2/Neu/ErbB2) is amplified and/or overexpressed in approximately 15% of human breast cancers [1] and plays a direct role in tumor development [2, 3]. Here, ERBB2 is linked to breast carcinoma.